ELLEN BOERSMA: Open Payments
NPI 1265684633 · LAKEPORT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 15 payments from 11 companies in 2025. Trend: 2023 $1,063 · 2024 $1,308 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $74 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Astellas Pharma US Inc | 1 | $34 |
| Stemline Therapeutics Inc. | 1 | $34 |
| BeiGene USA, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| Novocure Inc. | 1 | $16 |
Products named: KEYTRUDA, Enhertu, ERLEADA, RYBREVANT, Xtandi, Orserdu, BRUKINSA, ORGOVYX.
Industry payments across CA — which companies pay providers there.
